Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REPlaCE- Randomized Trial Evaluating the Use of Prothrombin Complex concEntrate to Improve Survival in Patients With Traumatic Coagulopathy

NCT03981484 is registered in ClinicalTrials.gov with Bellal A. Joseph, MD, FACS as lead sponsor.

NCT NCT03981484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03981484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REPlaCE- Randomized Trial Evaluating the Use of Prothrombin Complex concEntrate to Improve Survival in Patients With Traumatic Coagulopathy
Lead sponsor
Bellal A. Joseph, MD, FACS
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2020
Completion date
January 31, 2023
Enrollment
280 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coagulopathy, hemorrhage